Sequential testing, they think, would work best to screen candidates for clinical trials. Plasma p-tau217 and tau-PET imaging both predict cognitive decline. In cognitively normal people, the two ...

Veravas, a leader in clinical diagnostics, today announced the general commercial availability of VeraBIND™ Tau, the first blood-based test designed to aid in the detection of Alzheimer's disease (AD) ...

Enigma Biomedical USA Inc. has selected two four-repeat tau (4R tau) protein PET imaging biomarkers to advance into phase I studies. These imaging biomarkers show promise as important new tools in ...

By quantifying the amount of tau in the brain tissue with PET imaging, physicians can appropriately stage Alzheimer's disease ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of ...

ARUP Laboratories has introduced a blood test for phosphorylated tau 217 (pTau 217) to aid in diagnosing the pathology of ...

This collaboration will focus on demonstrating the value of 4R Tau PET imaging biomarkers in advancing our understanding of CTE.

ARUP Laboratories now provides a blood test for phosphorylated tau 217 (pTau 217) to assist in identifying whether cognitive decline symptoms in patients ages 60 years and older are related to ...